⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9762 | 1.00 | — | — | |
| SCHEMBL3807883 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11300796 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL11312698 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL11299132 | 0.97 | — | — | |
| SCHEMBL2509780 | 0.86 | TSHR (0.44) | — | |
| SCHEMBL12847437 | 0.80 | — | — | |
| SCHEMBL12371255 | 0.80 | — | — | |
| SCHEMBL29163760 | 0.76 | TSHR (0.38) | — | |
| SCHEMBL838105 | 0.74 | TSHR (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332434-B2 | Synthesis of levomethadone hydrochloride | SAFAEI GHOMI JAVAD (IR) | 2022-05-17 | — | — | US | claimed |
| WO-2020212890-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE | SAFAEI GHOMI JAVAD (IR) | 2020-10-22 | — | — | WO | claimed |
| US-20200277250-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE | SAFAEI GHOMI JAVAD (IR) | 2020-09-03 | — | — | US | claimed |
| US-20190002394-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | CODY LABORATORIES, INC. | 2019-01-03 | — | — | US | claimed |
| US-10040752-B2 | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof | CODY LABORATORIES, INC. (US) | 2018-08-07 | — | — | US | claimed |
| EP-3341354-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | Cody Laboratories, Inc. (US) | 2018-07-04 | — | — | EP | claimed |
| US-20170057909-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | ALTER DOMUS (US) LLC | 2017-03-02 | — | — | US | claimed |
| WO-2017035224-A1 | SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF | CODY LABORATORIES, INC. (US) | 2017-03-02 | — | — | WO | claimed |
| US-20250171432-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2025-05-29 | — | — | US | disclosed |
| US-20250163048-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2025-05-22 | — | — | US | disclosed |
| CN-119431406-A | Tricyclic compounds and medical uses thereof | 正大天晴药业集团股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4469447-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4469455-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20230384333-A1 | GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-11-30 | — | — | US | disclosed |
| EP-1507530-B1 | DIAMINOTHIAZOLES AND USE THEREOF AS CDK4 INHIBITORS | HOFFMANN LA ROCHE (CH) | 2005-11-02 | — | — | EP | disclosed |
| EP-1507530-A1 | DIAMINOTHIAZOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-02-23 | — | — | EP | disclosed |
| US-6818663-B2 | AS INHIBITORS OF CYCLIN-DEPENDENT KINASE 4 (CDK4); ANTIPROLIFERATIVE AGENTS; FOR THERAPY OF CANCER, TUMORS | HOFFMANN-LA ROCHES | 2004-11-16 | — | — | US | disclosed |
| WO-2004093880-A1 | 4-ANILINO-QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | ASTRAZENECA AB (SE) | 2004-11-04 | — | — | WO | disclosed |
| US-20040006058-A1 | DIAMINOTHIAZOLES | CHU XIN-JIE (US) | 2004-01-08 | — | — | US | disclosed |
| WO-2003097048-A1 | DIAMINOTHIAZOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-11-27 | — | — | WO | disclosed |